Division of Cardiology, Cook County Health, Chicago, IL, USA.
Division of Cardiology, University of Tennessee Health Science Center, Memphis, TN, USA.
Nephrol Dial Transplant. 2020 Mar 1;35(3):526-533. doi: 10.1093/ndt/gfz063.
Mitral annular calcification (MAC) is associated with increased risk of major adverse cardiac events. We hypothesized that MAC, identified on a pretransplant transthoracic echocardiography (TTE), is predictive of cardiac events following renal transplantation (RT).
In a retrospective cohort of consecutive RT recipients, pretransplant MAC presence and severity were determined on TTE performed within 1 year prior to transplant. MAC severity was quantified based on the circumferential MAC extension relative to the mitral valve annulus. Post-transplant cardiac risk was assessed using the sum of risk factors (range: 0-8) set forth by the American Heart Association/American College of Cardiology Foundation consensus statement on the assessment of RT candidates. Subjects underwent pretransplant stress single-photon emission computed tomography myocardial perfusion imaging and followed for post-transplant composite outcome of cardiac death or myocardial infarction (CD/MI).
Among 336 subjects (60.5% men; mean age 52 ± 12 years), MAC was present in 78 (23%) patients. During a mean follow-up of 3.1 ± 1.9 years, a total of 70 events were observed. Patients with MAC had a higher event rate compared with those without MAC (34.6% versus 17.8%, log-rank P = 0.001). There was a stepwise increase in CD/MI risk with increasing MAC severity (P for trend = 0.002). MAC-associated risk remained significant after adjusting for sex, duration of dialysis, sum of risk factors, ejection fraction and perfusion abnormality burden, providing an incremental prognostic value to these parameters (Δχ2 =4.63; P = 0.031).
Among RT recipients, the burden of pretransplant MAC is an independent predictor of post-transplant risk of CD/MI. MAC should be considered in the preoperative assessment of RT candidates.
二尖瓣环钙化(MAC)与主要不良心脏事件的风险增加相关。我们假设,在移植前 1 年内进行的经胸超声心动图(TTE)上识别出的 MAC 可预测肾移植(RT)后的心脏事件。
在连续接受 RT 的患者的回顾性队列中,在移植前 1 年内进行的 TTE 上确定 MAC 的存在和严重程度。MAC 的严重程度是根据 MAC 相对于二尖瓣环的周向延伸来量化的。使用美国心脏协会/美国心脏病学院基金会共识声明中规定的 RT 候选者评估的危险因素总和(范围:0-8)来评估移植后的心脏风险。受试者接受了移植前应激单光子发射计算机断层扫描心肌灌注成像,并随访移植后心脏死亡或心肌梗死(CD/MI)的复合结局。
在 336 名患者(60.5%为男性;平均年龄 52±12 岁)中,78 名(23%)患者存在 MAC。在平均 3.1±1.9 年的随访期间,共观察到 70 例事件。有 MAC 的患者的事件发生率高于没有 MAC 的患者(34.6%比 17.8%,对数秩 P=0.001)。随着 MAC 严重程度的增加,CD/MI 风险呈逐步增加(趋势 P=0.002)。在调整性别、透析时间、危险因素总和、射血分数和灌注异常负担后,MAC 相关风险仍然显著,为这些参数提供了增量预后价值(Δχ2=4.63;P=0.031)。
在 RT 受者中,移植前 MAC 的负担是移植后 CD/MI 风险的独立预测因子。MAC 应在 RT 候选者的术前评估中考虑。